What the Nutrition Progress Note actually produces

**Client:** Maria Gonzalez, 54F. **Diagnoses:** Type 2 Diabetes Mellitus, Hyperlipidemia. **Referring Provider:** Dr. Patel (endocrinology). **Setting:** Acme Health Clinic. **Visit Type:** Follow-up, 3-month interval. **Date of Visit:** [input-derived; actual date verify]. **Prior Visit:** ~12 weeks ago (baseline). **Current Anthropometric Data:** Weight 187 lb (↓6 lb since last visit, ~3.2% loss), BMI 31.2. Height assumed constant from baseline [verify]. **Lab Values (most recent):** A1C 7.1% (↓from 8.4% at baseline = 1.3% improvement); LDL 112 mg/dL (↓from 138); HDL [not provided — verify]; TG [not provided — verify]; BP 128/80 mmHg (systolic unchanged, diastolic ↓from 82). **Dietary Adherence:** Good adherence to low-glycemic meal plan; successfully reduced refined carbohydrates and sugary beverages; eats out ~2x/week with improved menu selections; occasional difficulty with portion control at dinner (primary barrier). **Interventions Provided This Session:** Reinforced carb-counting target of 45g/meal; introduced plate method visual aid (50% vegetables, 25% protein, 25% whole grain); adjusted evening snack composition to include protein (reduces glucose spikes); referred to diabetes education group class (biweekly, starts next month).

**Weight Trend:** 6 lb loss over 12 weeks = 0.5 lb/week, consistent with modest caloric deficit and sustainable approach. Trajectory supports continued intervention; no rapid loss suggesting disordered eating [verify]. **Glucose Control Progression:** A1C 8.4% → 7.1% = 1.3% absolute reduction, exceeding typical 0.5–1.0% expected improvement in first 3 months on structured intervention. Fasting blood glucose: [not provided — verify], but A1C trend strongly suggests improved glucose excursion control and adherence to carb-counting strategy. **Lipid Trend:** LDL 138 → 112 mg/dL (↓26 mg/dL); reflects reduction in refined carbs and improvement in meal composition. HDL and TG improvements [not provided — verify]; recommend lab recheck to assess full lipid response. **Blood Pressure:** Systolic 128 (unchanged), diastolic 82 → 80 (slight improvement). Continued monitoring; goal typically <130/80 for diabetes per [verify provider/guideline target]. **Dietary Adherence & Barriers:** Client demonstrates strong compliance overall (carb reduction, sugary beverage elimination, eating-out behavior modification). Dinner portion control remains challenging; likely driven by end-of-day hunger or habit. Evening snack adjustment (protein addition) designed to address blood glucose stability pre-dinner.

**Modified Goals:** (1) Achieve A1C <7.0% by next visit (6 weeks); current trajectory supports this. (2) Lose additional 2–3 lb by 6-week check-in (gradual, sustainable). (3) Demonstrate consistent plate method use at home meals (target: ≥5 days/week). (4) Attend diabetes education group (encourage attendance at ≥4 sessions in next 6 weeks). **Nutrition Care Plan Adjustments:** Continue low-glycemic meal structure (45g carbs per meal, 15g per snack [input-derived target; verify with provider]). Emphasize dinner portion control strategy: pre-plate meal components before sitting (reduces overeating); practice mindful eating (slow pace, 20-min minimum meal duration). Add pre-dinner walk (10–15 min) to reduce blood glucose rise post-meal [verify activity clearance]. Introduce food logging app trial (if client technologically comfortable) to self-monitor portion and carb intake. **Follow-up Schedule:** Phone check-in 2 weeks post-visit to assess evening snack compliance and address barriers. In-person reassessment 6 weeks (weight, dietary recall, A1C recheck if ordered). If diabetes education group starts, coordinate messaging (avoid conflicting guidance). **Justification for Continued Nutrition Therapy:** Client demonstrates measurable progress (A1C reduction, weight loss, behavioral change) and ongoing barrier (portion control). Continued RD support is medically necessary to reinforce strategies, address emerging barriers, and optimize diabetes management and lipid control. Referral to group education provides cost-effective peer support.